**About the Editor**

#### **Cristina M. Ramo-Tello**

Cristina M. Ramo-Tello, MD (University of Zaragoza, Spain), trained as a specialist in neurology (12 de Octubre Hospital, Madrid), obtained her PhD on the treatment of multiple sclerosis relapse. She has dedicated her professional career to general neurology and multiple sclerosis. She is currently the Head of the Multiple Sclerosis Unit of Germans Trias i Pujol Hospital in Badalona, Spain. Her specialization and dedication to MS and neuroimmunology dates back to the 1990s. In terms of research topics, she has developed in particular the study of the treatment of multiple sclerosis relapse and the treatment of multiple sclerosis by the transplantation of autologous mesenchymal cells or by dendritic cells tolerant against myelin peptides. Her research lines are all funded by official national and European grants, which have led to doctoral degrees and international publications. Other lines of research include the search for diagnostic and prognostic biomarkers.
